Stay updated on GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.

Latest updates to the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPage revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedA site-wide notice about government funding and potential delays in updates has been removed. The core study information on the page remains unchanged.SummaryDifference0.4%

- Check42 days agoChange DetectedThe screenshots show layout and formatting adjustments to the study record page with no changes to the core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference6%

- Check78 days agoChange DetectedUpdate core page revision from v3.0.2 to v3.1.0 by adding v3.1.0 and removing v3.0.2.SummaryDifference0.1%

- Check92 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; removed the non-essential 'Back to Top' element.SummaryDifference0.3%

Stay in the know with updates to GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GMI-1359 Safety in HR+ Metastatic Breast Cancer Clinical Trial page.